Issues and updates in emerging neurologic viral infections

Seminars in Neurology

Volumn 31, Issue 3, 2011, Pages 245-253

  Wilson, Michael R ^a,b   Tyler, Kenneth L ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

autoimmune encephalitis; dengue fever; DNA microarray; H1N1 influenza virus; high throughput DNA pyrosequencing; MassTag PCR; Viral encephalitis

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; DENGUE VIRUS; DNA MICROARRAY; DNA SEQUENCE; ENCEPHALITIS; HASHIMOTO ENCEPHALOPATHY; HIGH THROUGHPUT SCREENING; HUMAN; INFLUENZA VIRUS A; MOLECULAR DIAGNOSIS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; VASCULITIS; VIRUS ENCEPHALITIS;

COMMUNICABLE DISEASES, EMERGING; ENCEPHALITIS, VIRAL; GENETIC TECHNIQUES; HUMANS; NERVOUS SYSTEM DISEASES; UNITED STATES; VIRION;

EID: 80053550791     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1287650     Document Type: Article

References (44)

1. Tyler K L. Emerging viral infections of the central nervous system: part 1. Arch Neurol 2009 66 8 939-948
2. Tyler K L. Emerging viral infections of the central nervous system: part 2. Arch Neurol 2009 66 9 1065-1074
3. Griffin D E. Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol 2010 91 2 95-101
4. Glaser C A., Gilliam S, Schnurr D et al, California Encephalitis Project, 1998-2000. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003 36 6 731-742 (Pubitemid 36337977)
5. Glaser C A., Honarmand S, Anderson L J. et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006 43 12 1565-1577 (Pubitemid 44901899)
6. Granerod J, Tam C C., Crowcroft N S., Davies N WS, Borchert M, Thomas S L. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology 2010 75 10 924-932
7. Lipkin W I. Microbe hunting in the 21st century. Proc Natl Acad Sci U S A 2009 106 1 6-7
8. Lipkin W I. Pathogen discovery. PLoS Pathog 2008 4 4 e1000002
9. Briese T, Palacios G, Kokoris M et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis 2005 11 2 310-313 (Pubitemid 40239252)
10. Lamson D, Renwick N, Kapoor V et al. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis 2006 194 10 1398-1402 (Pubitemid 44706508)
11. Palacios G, Briese T, Kapoor V et al. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis 2006 12 4 692-695
12. Dominguez S R., Briese T, Palacios G et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008 43 2 219-222
13. Wang D, Coscoy L, Zylberberg M et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 2002 99 24 15687-15692 (Pubitemid 35403992)
14. Wang D, Urisman A, Liu Y T. et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003 1 2 E2
15. Chiu C Y., Urisman A, Greenhow T L. et al. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J Pediatr 2008 153 1 76-83
16. Ksiazek T G., Erdman D, Goldsmith C S. et al, SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003 348 20 1953-1966 (Pubitemid 36569984)
17. Urisman A, Molinaro R J., Fischer N et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006 2 3 e25
18. Chiu C Y., Greninger A L., Kanada K et al. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A 2008 105 37 14124-14129
19. Kistler A L., Gancz A, Clubb S et al. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Virol J 2008 5 88
20. Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008 358 10 991-998 (Pubitemid 351347098)
21. Quan P L., Wagner T A., Briese T et al. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis 2010 16 6 918-925
22. Tunkel A R., Glaser C A., Bloch K C. et al, Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008 47 3 303-327 (Pubitemid 352013512)
23. Vincent A, Buckley C, Schott J M. et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004 127 Pt 3 701-712 (Pubitemid 38295483)
24. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011 10 1 63-74
25. Darnell R B., Posner J B. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 2006 33 3 270-298 (Pubitemid 43849931)
26. Jarius S, Hoffmann L A., Stich O et al. Relative frequency of VGKC and classical paraneoplastic antibodies in patients with limbic encephalitis. J Neurol 2008 255 7 1100-1101
27. Dalmau J, Gleichman A J., Hughes E G. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008 7 12 1091-1098
28. Prüss H, Dalmau J, Harms L et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010 75 19 1735-1739
29. Gable M S., Gavali S, Radner A et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009 28 12 1421-1429
30. de Jong M D., Bach V C., Phan T Q. et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005 352 7 686-691 (Pubitemid 40239216)
31. Bautista E, Chotpitayasunondh T, Gao Z et al, Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010 362 18 1708-1719
32. Centers for Disease Control and Prevention. CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009March 13, 2010. Available at: http://www.flu.gov/individualfamily/about/ h1n1/estimates-2009-h1n1.html Accessed August 26, 2011
33. Rellosa N, Bloch K C., Shane A L., Debiasi R L. Neurologic manifestations of pediatric novel h1n1 influenza infection. Pediatr Infect Dis J 2011 30 2 165-167
34. Fugate J E., Lam E M., Rabinstein A A., Wijdicks E FM. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol 2010 67 6 756-758
35. Denholm J T., Neal A, Yan B et al. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination. Neurology 2010 75 24 2246-2248
36. Schonberger L B., Bregman D J., Sullivan-Bolyai J Z. et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 19761977. Am J Epidemiol 1979 110 2 105-123 (Pubitemid 10209694)
37. Centers for Disease Control and Prevention (CDC). Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccineUnited States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010 59 21 657-661
38. Vellozzi C, Broder K R., Haber P et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine 2010 28 45 7248-7255
39. Gibbons R V., Vaughn D W. Dengue: an escalating problem. BMJ 2002 324 7353 1563-1566 (Pubitemid 34713137)
40. Domingues R B., Kuster G W., Onuki-Castro F L., Souza V A., Levi J E., Pannuti C S. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci 2008 267 1-2 36-40 (Pubitemid 351255548)
41. Soares C N., Faria L C., Peralta J M., de Freitas M RG, Puccioni-Sohler M. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 2006 249 1 19-24 (Pubitemid 44665903)
42. Kankirawatana P, Chokephaibulkit K, Puthavathana P, Yoksan S, Apintanapong S, Pongthapisit V. Dengue infection presenting with central nervous system manifestation. J Child Neurol 2000 15 8 544-547
43. Solomon T, Dung N M., Vaughn D W. et al. Neurological manifestations of dengue infection. Lancet 2000 355 9209 1053-1059 (Pubitemid 30162808)
44. Centers for Disease Control and Prevention (CDC). Locally acquired DengueKey West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010 59 19 577-581